Robitussin Cough Syrup Recall

Robitussin Cough Syrup Recall

Robitussin Cough Syrup Recall

The manufacturer of Robitussin cough syrup voluntarily recalled some of its popular products containing honey due to microbial contamination. Haleon, a consumer healthcare company, took eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult cough syrups off the market in January.

The recalled cough syrups are used to temporarily relieve symptoms occurring with cold, flu, hay fever, or other respiratory allergies.

Haleon told the Associated Press (AP) that the products may contain “dangerously high levels of yeast.” Honey contains yeast and the company found levels “beyond allowed measurements,” according to the AP report.

In an announcement posted on the U.S. Food and Drug Administration’s (FDA) website, Haleon stated that people with weakened immune systems who use the product could potentially experience severe or life-threatening fungal infections, such as fungemia, the presence of fungi or yeasts in the blood, or disseminated fungal infection, a condition where fungal pathogens spread throughout the body and potentially cause fatal infections.

Life-threatening infections are not likely to occur in people with healthy immune systems—the consumers most likely to use the product, according to Haleon.

“However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out,” the company said in its announcement.

Recalled Robitussin Cough Syrups List

The recall covers the following products:

  • Robitussin Honey CF Max Day Adult (4 oz), Lot Number: T10810. Expiration date: October 31, 2025.
  • Robitussin Honey CF Max Day Adult (8 oz). Lot numbers: T08730, T08731, T08732, and T08733, all with expiration dates of May 31, 2025. Also, Lot number: T10808 with an expiration date of September 30, 2025.
  • Robitussin Honey CF Max Nighttime Adult (8 oz). Lot numbers: T08740 and T08742 with the expiration date of June 30, 2026.

Haleon stated that consumers who bought the recalled Robitussin Honey cough syrups should stop using them.

Haleon further said that, to date, the company has not received any reports of adverse events related to the recall. However, Haleon advises consumers who have experienced any problems related to taking these cough syrups should contact their physician or healthcare provider.

Customers with questions can call Haleon at (800) 245-1040 Monday through Friday, 8 a.m. to 6 p.m. Eastern time, or email mystory.us@haleon.com.

Adverse reactions or quality problems experienced after taking the Robitussin cough syrups may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax:

  • To complete and submit the report online, go to: www.fda.gov/medwatch/report.htm
  • Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Source Links:

https://finance.yahoo.com/news/robitussin-cough-syrup-sold-nationwide-200421967.html
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/haleon-issues-voluntary-nationwide-recall-robitussin-honey-cf-max-day-adult-and-robitussin-honey-cf
https://pubmed.ncbi.nlm.nih.gov/33449153/#:~:text=These%20fungi%20are%20typically%20innocuous,million%20deaths%20worldwide%20each%20year.
https://apnews.com/article/robitussin-recall-fda-cough-syrup-05320c3846a7ce6aeac28ccbc86194e2#

Follow Us or Share this page: Kindly go to setting page and check the option "Place them manually"